Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Pfizer Ends CytomX "Probody" Cancer Collaboration

Pfizer has terminated its five-year-old partnership with CytomX Therapeutics to use its Probody™ drug-development platform to develop and commercialize ...

Forward this item to a colleague:

(Separate multiple addresses by commas)